[Pharmacological treatment compliance and a description of its associated factors in patients with myasthenia gravis].
CONCLUSIONS: In this cohort of myasthenia gravis patients, three out of five patients were not adherent to treatment. These patients tended to have more weakness, worse quality of life and higher risk of depression. Medication adherence should be assessed routinely in patients with myasthenia gravis.
PMID: 29251338 [PubMed - in process]
Source: Revista de Neurologia - Category: Neurology Authors: Idiaquez JF, Gonzalez S, Lasso-Penafiel J, Barnett C Tags: Rev Neurol Source Type: research
More News: Brain | Chile Health | Depression | International Medicine & Public Health | Myasthenia Gravis | Neurology | Study | Women